Glecirasib
Glecirasib (JAB-21822, KRAS G12C inhibitor 36) is a potent, and highly selective, covalent inhibitor of KRAS G12C. It exhibits promising anti-tumor activity in KRAS G12C-mutated pancreatic ductal adenocarcinoma (PDAC) , Non-Small Cell Lung Cancer(NSCLC), Colorectal Cancer (CRC) and other solid tumors.
| Trivial name | JAB-21822, KRAS G12C inhibitor 36 |
| Catalog Number | E1677 |
| Molecular Formula | C33H38N4O6 |
| CAS# | 2657613-87-9 |
| Size | 5mg |
| Supplier Page | http://www.selleckchem.com/products/glecirasib.html |
| Additional Information | https://file.selleck.cn/downloads/struct/E1677-Glecirasib-chemical-structure.png |